BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 27511715)

  • 21. Brain metastases: what's new with an old problem?
    Tsao MN; Khuntia D; Mehta MP
    Curr Opin Support Palliat Care; 2012 Mar; 6(1):85-90. PubMed ID: 22123260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update.
    Park HS; Chiang VL; Knisely JP; Raldow AC; Yu JB
    Expert Rev Anticancer Ther; 2011 Nov; 11(11):1731-8. PubMed ID: 22050022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma-induced brain metastases.
    McWilliams RR; Rao RD; Buckner JC; Link MJ; Markovic S; Brown PD
    Expert Rev Anticancer Ther; 2008 May; 8(5):743-55. PubMed ID: 18471047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time?
    Lo SS; Brown PD; Foote M; Chao ST; Chang EL; Sahgal A
    Expert Rev Anticancer Ther; 2017 Sep; 17(9):775-777. PubMed ID: 28737065
    [No Abstract]   [Full Text] [Related]  

  • 26. The radiation oncologist's perspective on stereotactic radiosurgery.
    Regine W
    Technol Cancer Res Treat; 2002 Feb; 1(1):43-9. PubMed ID: 12614176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts and controversies in the treatment of parenchymal brain metastases: improved outcomes with aggressive management.
    Bajaj GK; Kleinberg L; Terezakis S
    Cancer Invest; 2005; 23(4):363-76. PubMed ID: 16100948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic therapy of brain metastases.
    Brastianos HC; Cahill DP; Brastianos PK
    Curr Neurol Neurosci Rep; 2015; 15(2):518. PubMed ID: 25492479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
    Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC
    J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of recurrent brain metastasis after radiosurgery.
    Stockham AL; Suh JH; Chao ST; Barnett GH
    Prog Neurol Surg; 2012; 25():273-86. PubMed ID: 22236688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic radiotherapy for large solitary brain metastases.
    Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
    Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.
    Tallet AV; Dhermain F; Le Rhun E; Noël G; Kirova YM
    Ann Oncol; 2017 Dec; 28(12):2962-2976. PubMed ID: 29045524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognition and radiation therapy for brain metastases: a new paradigm to define].
    Tallet A; Dhermain F; Taillia H; Ricard D; Mornex F; Métellus P
    Bull Cancer; 2013 Jan; 100(1):69-74. PubMed ID: 23302115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination of stereotactic irradiation and chemotherapy or targeted therapies: state of the art and preliminary recommendations].
    Thariat J; Kirova Y; Milano G; Mornex F
    Cancer Radiother; 2014; 18(4):270-9. PubMed ID: 25053603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current strategies in the surgical management of cerebral metastases: an evidence-based review.
    Siu TL; Jeffree RL; Fuller JW
    J Clin Neurosci; 2011 Nov; 18(11):1429-34. PubMed ID: 21868230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic radiation therapy of brain metastases from colorectal cancer: A single institution cohort.
    Paix A; Antoni D; Adeduntan R; Noël G
    Cancer Radiother; 2017 May; 21(3):199-204. PubMed ID: 28499660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.